Femoro Acetabular Impingement Clinical Trial
Official title:
The Innovation of 3D Printing for Preoperative Planning in Hip Preservation Surgery
Verified date | September 2023 |
Source | Nova Scotia Health Authority |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a randomized controlled trial (RCT) to evaluate the introduction of a 3D printed model into the pre and intra-operative planning for arthroscopic femoroacetabular impingement (FAI) surgery. The RCT will look to place patients into one of two treatment groups: 1) conventional preoperative imaging (X-ray, CT, and MRI) only and 2) those that have had a 3D printed model created in addition to the conventional imaging.
Status | Enrolling by invitation |
Enrollment | 80 |
Est. completion date | December 31, 2024 |
Est. primary completion date | August 31, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Radiological proven diagnosis of cam-type femoroacetabular impingement (FAI) Exclusion Criteria: - Patients with advanced arthritis (Tonnis Grade III or Kellgren-Lawrence Grade III or IV or evidence of less than 2 mm of joint space, as determined by conventional radiographs.) - Patients with 1cm2 (or greater) of cartilage delamination in the hip - Patients with type III or IV heterotopic ossification - Patients with avascular necrosis - Patients who are unable to provide informed consent - Patients who are undergoing revision hip arthroscopy - Patients who are pregnant - Patients who have the presence of local or systemic infection - Patients with an inability to cooperate with and/or comprehend post-operative instructions - Patients with nonvascular surgical sites (MRI proven) - Patients with cancer |
Country | Name | City | State |
---|---|---|---|
Canada | 5955 Veterans' Memorial Lane Room 2106, VMB | Halifax | Nova Scotia |
Lead Sponsor | Collaborator |
---|---|
Nova Scotia Health Authority |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | The number of times conventional imaging and 3D prints are referenced intra-operatively. | Another secondary outcome is the number of times each of the following are referenced intra-operatively: X-Rays, MRI, MRA, CT, CT with 3D reconstruction and 3D model of patient's hip. Additionally the number of X-Ray images taken intra-operatively will be recorded. | During surgery only | |
Primary | Measure of CAM resection | Our primary outcome for this study is the resection of cam impingement according to alpha-angle on post-operative anterior-posterior (AP) and frog leg X-ray views. | Change in Pre-op measurements compared to 2 weeks post-operatively | |
Primary | Measure of CAM resection | Our primary outcome for this study is the resection of cam impingement according to alpha-angle on post-operative anterior-posterior (AP) and frog leg X-ray views. | Change in Pre-op measurements compared to 6 months post-operatively | |
Primary | Measure of CAM resection | Our primary outcome for this study is the resection of cam impingement according to alpha-angle on post-operative anterior-posterior (AP) and frog leg X-ray views. | Change in Pre-op measurements compared to 24 months post-operatively | |
Secondary | Differences in post-operative patient reported outcomes: iHOT-33 | The secondary outcome is the differences in post-operative patient reported outcomes for the international hip outcome tool (iHOT-33) when compared to a pre-operative baseline. (Scores for the International hip outcome tool range from 0-100 where higher values represent better outcomes) | Change in outcomes 24 months post operatively compared to Pre-operatively | |
Secondary | Differences in post-operative patient reported outcomes: NAHS | The secondary outcome is the differences in post-operative patient reported outcomes for the Non-arthritic Hip Score (NAHS) when compared to a pre-operative baseline. (Scores for the Non-arthritic Hip Score range from 0-80 where higher values represent better outcomes). | Change in outcomes 24 months post operatively compared to Pre-operatively | |
Secondary | Differences in post-operative patient reported outcomes: EQ5D | The secondary outcome is the differences in post-operative patient reported outcomes for the European Quality of Life Questionnaire (EQ-5D) when compared to a pre-operative baseline. (Scores for EQ-5D range from 1-5 in 5 categories where lower values represent better outcomes in each category). | Change in outcomes 24 months post operatively compared to Pre-operatively | |
Secondary | Differences in post-operative patient reported outcomes: EQ5D-VAS | The secondary outcome is the differences in post-operative patient reported outcomes for the European Quality of Life Questionnaire-Visual Analog Scale (EQ-5D-VAS) when compared to a pre-operative baseline. (Scores for EQ-5D-VAS range from 0-100 where higher values represent better outcomes). | Change in outcomes 24 months post operatively compared to Pre-operatively | |
Secondary | Differences in post-operative patient reported outcomes: VR-12 | The secondary outcome is the differences in post-operative patient reported outcomes for the Veteran's RAND 12 Item Health Survey (VR-12) when compared to a pre-operative baseline. (Scores for VR-12 range from 0-100 where higher values represent better outcomes). | Change in outcomes 24 months post operatively compared to Pre-operatively | |
Secondary | Differences in post-operative patient reported outcomes: HOS-Usual Activities | The secondary outcome is the differences in post-operative patient reported outcomes for the Hip Outcome Score for usual activities (HOS-UA) when compared to a pre-operative baseline. (Scores for HOS range from 0-68 where higher values represent better outcomes). | Change in outcomes 24 months post operatively compared to Pre-operatively | |
Secondary | Differences in post-operative patient reported outcomes: HOS-Sport | The secondary outcome is the differences in post-operative patient reported outcomes for the Hip Outcome Score for sports (HOS-S) when compared to a pre-operative baseline. (Scores for HOS range from 0-30 where higher values represent better outcomes). | Change in outcomes 24 months post operatively compared to Pre-operatively |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03909139 -
Use of BMAC With Hip Arthroscopy Treatment of FAI and Labral Tear
|
||
Recruiting |
NCT05280899 -
Weightbearing Restrictions on Postoperative Outcomes Following Arthroscopic Surgery for FAI
|
N/A | |
Completed |
NCT05867069 -
Analysis of Radiographic and Kinematic Features in FAI Patients
|
||
Active, not recruiting |
NCT04418596 -
Longitudinal Follow-up of Male Soccer Players Prone to Developing CAM Hip Deformity
|
||
Completed |
NCT04114058 -
A Study Comparing Fascia Iliaca Blockade vs Extracapsular Local Field Infiltration With Liposomal Bupivacaine
|
Phase 4 | |
Active, not recruiting |
NCT03909178 -
Arthroscopic Labral Repair Versus Physical Therapy for Tears of the Acetabular Labrum
|
N/A | |
Recruiting |
NCT05687955 -
Exercise Rehabilitation for Hip-related Pain and Dysfunction in Student Circus Arts Performers
|
N/A | |
Recruiting |
NCT05853640 -
Education and Exercise for Patients With Longstanding Hip and Groin Pain
|
N/A | |
Not yet recruiting |
NCT06420180 -
Effect of Lower Limb Rotation on Clinical Outcomes After Arthroscopic Management in Patients With Symptomatic Femoroacetabular Impingement Syndrome
|
||
Enrolling by invitation |
NCT01575964 -
Biomechanical Assessment of Femoroacetabular Impingement
|
||
Completed |
NCT04590924 -
HAFAI Cohort 5 Year Follow up of Patients With Femoroacetabular Impingement Undergoing Hip Arthroscopy
|
||
Completed |
NCT03453866 -
Effect of Warmed Irrigation in Hip Arthroscopy Undergoing Hip Arthroscopy
|
N/A | |
Recruiting |
NCT06198829 -
Evaluation of the Clinical Parameters and Kinesiophobia in Femoroacetabular Impingement Syndrome
|
||
Completed |
NCT03407612 -
Outcomes of CPM Usage Following Arthroscopic Acetabular Labral Repair
|
N/A | |
Withdrawn |
NCT05710146 -
Tranexamic Acid (TXA) in Hip Arthroscopy
|
Phase 3 | |
Recruiting |
NCT06003101 -
Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies
|
Phase 3 | |
Not yet recruiting |
NCT06462482 -
Peri-Operative Testosterone Administration in Primary Hip Arthroscopy
|
Phase 4 | |
Not yet recruiting |
NCT06327217 -
Long Term Results After Hip Arthroscopy
|
||
Not yet recruiting |
NCT06288867 -
A 12 Months Prospective Study Comparing Functional Outcome Scores in Hip Arthroscopic Labral Repair Versus Debridement
|
N/A |